AGQ Labs, authorized by the Public Health Institute of Chile for medicines analysis
05/12/2011 - Biopharmaceutics
Within the diversification policy of AGQ Labs, since a year ago we have been working on a new business division: biopharmaceuticals. Following the implementation of specific technical department, responsible for channeling all work in this area, we have developed various methods of work and specific methods for the analysis of drugs.

All this structure is oriented by studies involving biopharmaceutical giving value to the bioanalytical phase. Our certifications and experience allows us to provide security and reliability of results as well as ensuring the confidentiality of the same. Most of these studies aimed at studying the bioavailability and/or bioequivalence, this is, evaluate whether the generic medicines meet the requirements that different public administrations demand.
